Видео ютуба по тегу Supriya Lifescience

Currently 89% Of Sales Are Exports; Not Worried About Competition From China: Supriya Lifescience
Currently 89% Of Sales Are Exports; Not Worried About Competition From China: Supriya Lifescience
Supriya Lifescience Earnings Call for Q2FY25
Supriya Lifescience Earnings Call for Q2FY25
Supriya Lifescience: Margin Expansion On The Cards? | Know Your Company
Supriya Lifescience: Margin Expansion On The Cards? | Know Your Company
Highligts of the Listing Ceremony of Supriya Lifescience Limited
Highligts of the Listing Ceremony of Supriya Lifescience Limited
Supriya Lifescience's Saloni Wagh On Q4 Performance & Business Outlook | Chartbusters | CNBCTV18
Supriya Lifescience's Saloni Wagh On Q4 Performance & Business Outlook | Chartbusters | CNBCTV18
Supriya Lifescience Corporate Film
Supriya Lifescience Corporate Film
Supriya Lifescience: Total Capacity To Rise From 597 KL To 900 KL By Q2
Supriya Lifescience: Total Capacity To Rise From 597 KL To 900 KL By Q2
Red Sea Issues Have Led To Delay In Consignment Exports: Supriya Lifescience | CNBC TV18
Red Sea Issues Have Led To Delay In Consignment Exports: Supriya Lifescience | CNBC TV18
IPO Review Of Supriya Lifescience Ltd with Satish Wagh an Saloni Wagh On – ICICI Direct
IPO Review Of Supriya Lifescience Ltd with Satish Wagh an Saloni Wagh On – ICICI Direct
Listing Ceremony of Supriya Lifescience Limited
Listing Ceremony of Supriya Lifescience Limited
Supriya Lifescience Ltd Q2 FY2024-25 Earnings Conference Call
Supriya Lifescience Ltd Q2 FY2024-25 Earnings Conference Call
Supriya Lifescience Ltd Investor Presentation for Q1FY25
Supriya Lifescience Ltd Investor Presentation for Q1FY25
Supriya Lifescience IPO | Will I Apply? | CA Rachana Ranade
Supriya Lifescience IPO | Will I Apply? | CA Rachana Ranade
Supriya Lifescience IPO Review - Apply or Not | Supriya Lifescience IPO Details | Angel One
Supriya Lifescience IPO Review - Apply or Not | Supriya Lifescience IPO Details | Angel One
Supriya Lifescience Ltd - Stock Outlook
Supriya Lifescience Ltd - Stock Outlook
Margin Will Remain Around 39%, Confident Of At Least 22-23% Growth In FY25: Supriya Lifescience
Margin Will Remain Around 39%, Confident Of At Least 22-23% Growth In FY25: Supriya Lifescience
Supriya Lifescience Ltd Q4 FY23 Earnings Concall
Supriya Lifescience Ltd Q4 FY23 Earnings Concall
Supriya Lifescience IPO Details & Review | Kotak Securities
Supriya Lifescience IPO Details & Review | Kotak Securities
Is Supriya Lifescience The Right Stock Addition To Your Portfolio? | Know Your Company
Is Supriya Lifescience The Right Stock Addition To Your Portfolio? | Know Your Company